Global Afatinib Market Growth (Status and Outlook) 2022-2028
- LP 4768516
- 60 Pages
- January 2022
- Pharmaceuticals
The United States Afatinib market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Afatinib market, reaching US$ million by the year 2028. As for the Europe Afatinib landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Afatinib players cover Boehringer Ingelheim, Hengrui Medicine, Beacon Pharma, and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Afatinib market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
30mg Tables
40mg Tables
50mg Tables
25mg Tables
20mg Tables
Other
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital
Clinic
Drug Center
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Boehringer Ingelheim
Hengrui Medicine
Beacon Pharma
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Afatinib Market Size 2017-2028
2.1.2 Afatinib Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Afatinib Segment by Type
2.2.1 30mg Tables
2.2.2 40mg Tables
2.2.3 50mg Tables
2.2.4 25mg Tables
2.2.5 20mg Tables
2.2.6 Other
2.3 Afatinib Market Size by Type
2.3.1 Afatinib Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Afatinib Market Size Market Share by Type (2017-2022)
2.4 Afatinib Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Drug Center
2.4.4 Other
2.5 Afatinib Market Size by Application
2.5.1 Afatinib Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Afatinib Market Size Market Share by Application (2017-2022)
3 Afatinib Market Size by Player
3.1 Afatinib Market Size Market Share by Players
3.1.1 Global Afatinib Revenue by Players (2020-2022)
3.1.2 Global Afatinib Revenue Market Share by Players (2020-2022)
3.2 Global Afatinib Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Afatinib by Regions
4.1 Afatinib Market Size by Regions (2017-2022)
4.2 Americas Afatinib Market Size Growth (2017-2022)
4.3 APAC Afatinib Market Size Growth (2017-2022)
4.4 Europe Afatinib Market Size Growth (2017-2022)
4.5 Middle East & Africa Afatinib Market Size Growth (2017-2022)
5 Americas
5.1 Americas Afatinib Market Size by Country (2017-2022)
5.2 Americas Afatinib Market Size by Type (2017-2022)
5.3 Americas Afatinib Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Afatinib Market Size by Region (2017-2022)
6.2 APAC Afatinib Market Size by Type (2017-2022)
6.3 APAC Afatinib Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Afatinib by Country (2017-2022)
7.2 Europe Afatinib Market Size by Type (2017-2022)
7.3 Europe Afatinib Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Afatinib by Region (2017-2022)
8.2 Middle East & Africa Afatinib Market Size by Type (2017-2022)
8.3 Middle East & Africa Afatinib Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Afatinib Market Forecast
10.1 Global Afatinib Forecast by Regions (2023-2028)
10.1.1 Global Afatinib Forecast by Regions (2023-2028)
10.1.2 Americas Afatinib Forecast
10.1.3 APAC Afatinib Forecast
10.1.4 Europe Afatinib Forecast
10.1.5 Middle East & Africa Afatinib Forecast
10.2 Americas Afatinib Forecast by Country (2023-2028)
10.2.1 United States Afatinib Market Forecast
10.2.2 Canada Afatinib Market Forecast
10.2.3 Mexico Afatinib Market Forecast
10.2.4 Brazil Afatinib Market Forecast
10.3 APAC Afatinib Forecast by Region (2023-2028)
10.3.1 China Afatinib Market Forecast
10.3.2 Japan Afatinib Market Forecast
10.3.3 Korea Afatinib Market Forecast
10.3.4 Southeast Asia Afatinib Market Forecast
10.3.5 India Afatinib Market Forecast
10.3.6 Australia Afatinib Market Forecast
10.4 Europe Afatinib Forecast by Country (2023-2028)
10.4.1 Germany Afatinib Market Forecast
10.4.2 France Afatinib Market Forecast
10.4.3 UK Afatinib Market Forecast
10.4.4 Italy Afatinib Market Forecast
10.4.5 Russia Afatinib Market Forecast
10.5 Middle East & Africa Afatinib Forecast by Region (2023-2028)
10.5.1 Egypt Afatinib Market Forecast
10.5.2 South Africa Afatinib Market Forecast
10.5.3 Israel Afatinib Market Forecast
10.5.4 Turkey Afatinib Market Forecast
10.5.5 GCC Countries Afatinib Market Forecast
10.6 Global Afatinib Forecast by Type (2023-2028)
10.7 Global Afatinib Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Company Information
11.1.2 Boehringer Ingelheim Afatinib Product Offered
11.1.3 Boehringer Ingelheim Afatinib Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Boehringer Ingelheim Main Business Overview
11.1.5 Boehringer Ingelheim Latest Developments
11.2 Hengrui Medicine
11.2.1 Hengrui Medicine Company Information
11.2.2 Hengrui Medicine Afatinib Product Offered
11.2.3 Hengrui Medicine Afatinib Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Hengrui Medicine Main Business Overview
11.2.5 Hengrui Medicine Latest Developments
11.3 Beacon Pharma
11.3.1 Beacon Pharma Company Information
11.3.2 Beacon Pharma Afatinib Product Offered
11.3.3 Beacon Pharma Afatinib Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Beacon Pharma Main Business Overview
11.3.5 Beacon Pharma Latest Developments
12 Research Findings and Conclusion
Table 1. Afatinib Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of 30mg Tables
Table 3. Major Players of 40mg Tables
Table 4. Major Players of 50mg Tables
Table 5. Major Players of 25mg Tables
Table 6. Major Players of 20mg Tables
Table 7. Major Players of Other
Table 8. Afatinib Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Afatinib Market Size by Type (2017-2022) & ($ Millions)
Table 10. Global Afatinib Market Size Market Share by Type (2017-2022)
Table 11. Afatinib Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 12. Global Afatinib Market Size by Application (2017-2022) & ($ Millions)
Table 13. Global Afatinib Market Size Market Share by Application (2017-2022)
Table 14. Global Afatinib Revenue by Players (2020-2022) & ($ Millions)
Table 15. Global Afatinib Revenue Market Share by Player (2020-2022)
Table 16. Afatinib Key Players Head office and Products Offered
Table 17. Afatinib Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Afatinib Market Size by Regions 2017-2022 & ($ Millions)
Table 21. Global Afatinib Market Size Market Share by Regions (2017-2022)
Table 22. Americas Afatinib Market Size by Country (2017-2022) & ($ Millions)
Table 23. Americas Afatinib Market Size Market Share by Country (2017-2022)
Table 24. Americas Afatinib Market Size by Type (2017-2022) & ($ Millions)
Table 25. Americas Afatinib Market Size Market Share by Type (2017-2022)
Table 26. Americas Afatinib Market Size by Application (2017-2022) & ($ Millions)
Table 27. Americas Afatinib Market Size Market Share by Application (2017-2022)
Table 28. APAC Afatinib Market Size by Region (2017-2022) & ($ Millions)
Table 29. APAC Afatinib Market Size Market Share by Region (2017-2022)
Table 30. APAC Afatinib Market Size by Type (2017-2022) & ($ Millions)
Table 31. APAC Afatinib Market Size Market Share by Type (2017-2022)
Table 32. APAC Afatinib Market Size by Application (2017-2022) & ($ Millions)
Table 33. APAC Afatinib Market Size Market Share by Application (2017-2022)
Table 34. Europe Afatinib Market Size by Country (2017-2022) & ($ Millions)
Table 35. Europe Afatinib Market Size Market Share by Country (2017-2022)
Table 36. Europe Afatinib Market Size by Type (2017-2022) & ($ Millions)
Table 37. Europe Afatinib Market Size Market Share by Type (2017-2022)
Table 38. Europe Afatinib Market Size by Application (2017-2022) & ($ Millions)
Table 39. Europe Afatinib Market Size Market Share by Application (2017-2022)
Table 40. Middle East & Africa Afatinib Market Size by Region (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Afatinib Market Size Market Share by Region (2017-2022)
Table 42. Middle East & Africa Afatinib Market Size by Type (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Afatinib Market Size Market Share by Type (2017-2022)
Table 44. Middle East & Africa Afatinib Market Size by Application (2017-2022) & ($ Millions)
Table 45. Middle East & Africa Afatinib Market Size Market Share by Application (2017-2022)
Table 46. Key Market Drivers & Growth Opportunities of Afatinib
Table 47. Key Market Challenges & Risks of Afatinib
Table 48. Key Industry Trends of Afatinib
Table 49. Global Afatinib Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 50. Global Afatinib Market Size Market Share Forecast by Regions (2023-2028)
Table 51. Global Afatinib Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 52. Global Afatinib Market Size Market Share Forecast by Type (2023-2028)
Table 53. Global Afatinib Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 54. Global Afatinib Market Size Market Share Forecast by Application (2023-2028)
Table 55. Boehringer Ingelheim Details, Company Type, Afatinib Area Served and Its Competitors
Table 56. Boehringer Ingelheim Afatinib Product Offered
Table 57. Boehringer Ingelheim Afatinib Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 58. Boehringer Ingelheim Main Business
Table 59. Boehringer Ingelheim Latest Developments
Table 60. Hengrui Medicine Details, Company Type, Afatinib Area Served and Its Competitors
Table 61. Hengrui Medicine Afatinib Product Offered
Table 62. Hengrui Medicine Main Business
Table 63. Hengrui Medicine Afatinib Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 64. Hengrui Medicine Latest Developments
Table 65. Beacon Pharma Details, Company Type, Afatinib Area Served and Its Competitors
Table 66. Beacon Pharma Afatinib Product Offered
Table 67. Beacon Pharma Main Business
Table 68. Beacon Pharma Afatinib Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 69. Beacon Pharma Latest Developments
List of Figures
Figure 1. Afatinib Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Afatinib Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Afatinib Market Size Market Share by Type in 2021
Figure 7. Afatinib in Hospital
Figure 8. Global Afatinib Market: Hospital (2017-2022) & ($ Millions)
Figure 9. Afatinib in Clinic
Figure 10. Global Afatinib Market: Clinic (2017-2022) & ($ Millions)
Figure 11. Afatinib in Drug Center
Figure 12. Global Afatinib Market: Drug Center (2017-2022) & ($ Millions)
Figure 13. Afatinib in Other
Figure 14. Global Afatinib Market: Other (2017-2022) & ($ Millions)
Figure 15. Global Afatinib Market Size Market Share by Application in 2021
Figure 16. Global Afatinib Revenue Market Share by Player in 2021
Figure 17. Global Afatinib Market Size Market Share by Regions (2017-2022)
Figure 18. Americas Afatinib Market Size 2017-2022 ($ Millions)
Figure 19. APAC Afatinib Market Size 2017-2022 ($ Millions)
Figure 20. Europe Afatinib Market Size 2017-2022 ($ Millions)
Figure 21. Middle East & Africa Afatinib Market Size 2017-2022 ($ Millions)
Figure 22. Americas Afatinib Value Market Share by Country in 2021
Figure 23. Americas Afatinib Consumption Market Share by Type in 2021
Figure 24. Americas Afatinib Market Size Market Share by Application in 2021
Figure 25. United States Afatinib Market Size Growth 2017-2022 ($ Millions)
Figure 26. Canada Afatinib Market Size Growth 2017-2022 ($ Millions)
Figure 27. Mexico Afatinib Market Size Growth 2017-2022 ($ Millions)
Figure 28. Brazil Afatinib Market Size Growth 2017-2022 ($ Millions)
Figure 29. APAC Afatinib Market Size Market Share by Region in 2021
Figure 30. APAC Afatinib Market Size Market Share by Application in 2021
Figure 31. China Afatinib Market Size Growth 2017-2022 ($ Millions)
Figure 32. Japan Afatinib Market Size Growth 2017-2022 ($ Millions)
Figure 33. Korea Afatinib Market Size Growth 2017-2022 ($ Millions)
Figure 34. Southeast Asia Afatinib Market Size Growth 2017-2022 ($ Millions)
Figure 35. India Afatinib Market Size Growth 2017-2022 ($ Millions)
Figure 36. Australia Afatinib Market Size Growth 2017-2022 ($ Millions)
Figure 37. Europe Afatinib Market Size Market Share by Country in 2021
Figure 38. Europe Afatinib Market Size Market Share by Type in 2021
Figure 39. Europe Afatinib Market Size Market Share by Application in 2021
Figure 40. Germany Afatinib Market Size Growth 2017-2022 ($ Millions)
Figure 41. France Afatinib Market Size Growth 2017-2022 ($ Millions)
Figure 42. UK Afatinib Market Size Growth 2017-2022 ($ Millions)
Figure 43. Italy Afatinib Market Size Growth 2017-2022 ($ Millions)
Figure 44. Russia Afatinib Market Size Growth 2017-2022 ($ Millions)
Figure 45. Middle East & Africa Afatinib Market Size Market Share by Region in 2021
Figure 46. Middle East & Africa Afatinib Market Size Market Share by Type in 2021
Figure 47. Middle East & Africa Afatinib Market Size Market Share by Application in 2021
Figure 48. Egypt Afatinib Market Size Growth 2017-2022 ($ Millions)
Figure 49. South Africa Afatinib Market Size Growth 2017-2022 ($ Millions)
Figure 50. Israel Afatinib Market Size Growth 2017-2022 ($ Millions)
Figure 51. Turkey Afatinib Market Size Growth 2017-2022 ($ Millions)
Figure 52. GCC Country Afatinib Market Size Growth 2017-2022 ($ Millions)
Figure 53. Americas Afatinib Market Size 2023-2028 ($ Millions)
Figure 54. APAC Afatinib Market Size 2023-2028 ($ Millions)
Figure 55. Europe Afatinib Market Size 2023-2028 ($ Millions)
Figure 56. Middle East & Africa Afatinib Market Size 2023-2028 ($ Millions)
Figure 57. United States Afatinib Market Size 2023-2028 ($ Millions)
Figure 58. Canada Afatinib Market Size 2023-2028 ($ Millions)
Figure 59. Mexico Afatinib Market Size 2023-2028 ($ Millions)
Figure 60. Brazil Afatinib Market Size 2023-2028 ($ Millions)
Figure 61. China Afatinib Market Size 2023-2028 ($ Millions)
Figure 62. Japan Afatinib Market Size 2023-2028 ($ Millions)
Figure 63. Korea Afatinib Market Size 2023-2028 ($ Millions)
Figure 64. Southeast Asia Afatinib Market Size 2023-2028 ($ Millions)
Figure 65. India Afatinib Market Size 2023-2028 ($ Millions)
Figure 66. Australia Afatinib Market Size 2023-2028 ($ Millions)
Figure 67. Germany Afatinib Market Size 2023-2028 ($ Millions)
Figure 68. France Afatinib Market Size 2023-2028 ($ Millions)
Figure 69. UK Afatinib Market Size 2023-2028 ($ Millions)
Figure 70. Italy Afatinib Market Size 2023-2028 ($ Millions)
Figure 71. Russia Afatinib Market Size 2023-2028 ($ Millions)
Figure 72. Spain Afatinib Market Size 2023-2028 ($ Millions)
Figure 73. Egypt Afatinib Market Size 2023-2028 ($ Millions)
Figure 74. South Africa Afatinib Market Size 2023-2028 ($ Millions)
Figure 75. Israel Afatinib Market Size 2023-2028 ($ Millions)
Figure 76. Turkey Afatinib Market Size 2023-2028 ($ Millions)
Figure 77. GCC Countries Afatinib Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
